News
VBIZF
0.295
NaN%
--
Weekly Report: what happened at VBIZF last week (0908-0912)?
Weekly Report · 09/15 10:34
Weekly Report: what happened at VBIZF last week (0901-0905)?
Weekly Report · 09/08 10:36
Weekly Report: what happened at VBIZF last week (0825-0829)?
Weekly Report · 09/01 10:32
Weekly Report: what happened at VBIZF last week (0818-0822)?
Weekly Report · 08/25 10:39
Weekly Report: what happened at VBIZF last week (0811-0815)?
Weekly Report · 08/18 10:34
Weekly Report: what happened at VBIZF last week (0804-0808)?
Weekly Report · 08/11 10:39
Weekly Report: what happened at VBIZF last week (0728-0801)?
Weekly Report · 08/04 10:41
Weekly Report: what happened at VBIZF last week (0721-0725)?
Weekly Report · 07/28 10:42
Weekly Report: what happened at VBIZF last week (0714-0718)?
Weekly Report · 07/21 10:34
Weekly Report: what happened at VBIZF last week (0707-0711)?
Weekly Report · 07/14 10:41
Weekly Report: what happened at VBIZF last week (0630-0704)?
Weekly Report · 07/07 10:35
Weekly Report: what happened at VBIZF last week (0623-0627)?
Weekly Report · 06/30 10:40
Weekly Report: what happened at VBIZF last week (0616-0620)?
Weekly Report · 06/23 10:35
Weekly Report: what happened at VBIZF last week (0609-0613)?
Weekly Report · 06/16 10:39
Weekly Report: what happened at VBIZF last week (0602-0606)?
Weekly Report · 06/09 10:40
Weekly Report: what happened at VBIZF last week (0526-0530)?
Weekly Report · 06/02 10:46
Weekly Report: what happened at VBIZF last week (0519-0523)?
Weekly Report · 05/26 10:46
Weekly Report: what happened at VBIZF last week (0512-0516)?
Weekly Report · 05/19 10:39
Weekly Report: what happened at VBIZF last week (0505-0509)?
Weekly Report · 05/12 10:39
Weekly Report: what happened at VBIZF last week (0428-0502)?
Weekly Report · 05/05 10:41
More
Webull provides a variety of real-time VBIZF stock news. You can receive the latest news about Viva Biotech Hol through multiple platforms. This information may help you make smarter investment decisions.
About VBIZF
VIVA Biotech Holdings is an investment holding company. The Company has two segments. The Drug Discovery Services segment provides structure-based drug discovery services to biotech and pharmaceutical clients for preclinical innovative drug development. The Contract Design and Manufacturing (CDMO) and Commercialization Services segment is engaged in contract development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, as well as the trading of APIs, intermediates and finished products. The Company conducts business primarily in the United States, China, Europe and other regions.